TP53 and melanoma: In a study on human hepatic cancer cells (SNU-387) and drug-resistant human melanoma Malme3M (Malme3M(R)), chromatin immunoprecipitation demonstrated that CAGE, via histone deacetylase 2 interactions, negatively affected p53 levels in Malme3M(R) cells.